Ulcerative Colitis
Moderate To Severe Ulcerative Colitis
The primary objective of this study is to evaluate the long-term safety and tolerability of an investigational medication in participants with moderate to severe ulcerative colitis (UC).
To qualify, you must:
- Be 18-80 years old
- Diagnosis of UC established at least 3 months prior to enrollment by clinical and endoscopic evidence
Why Participate?
Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.
Experience
The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.
Safety
Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.
ClinSearch
Study Hotline
+1-423-347-6279
Main Office
+1-423-698-4584
Our Hours
Mon-Fri: 8AM to 5PM
Location
6035 Shallowford Rd. Suite #109
Chattanooga, TN 37421